Results 11 to 20 of about 32,416 (217)

Pneumococcal Vaccines [PDF]

American Journal of Respiratory and Critical Care Medicine
01-Pneumococcal-Poehling-508 ...
Andrew, Gilmore, Justin, Ortiz
core   +37 more sources

Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies [PDF]

Vaccines, 2021
The importance of Streptococcus pneumoniae has been well established. These bacteria can colonize infants and adults without symptoms, but in some cases can spread, invade other tissues and cause disease with high morbidity and mortality. The development
Giuliana S. Oliveira, Maria Leonor S. Oliveira, Eliane N. Miyaji, Tasson C. Rodrigues   +3 more
doaj   +2 more sources

Pneumococcal vaccines in China. [PDF]

Hum Vaccin Immunother
Invasive pneumococcal disease (IPD) is a serious global public health problem and the leading cause of morbidity and mortality in children and adults in China. Thus, developing and administering pneumococcal vaccines are important for disease prevention.
Wang S, Li B, Chen Q, Wang C, Wang B, Ye Q, Xu Y.   +6 more
europepmc   +4 more sources

Pneumococcal Vaccines

Microbiology Spectrum, 2019
Streptococcus pneumoniae is a Gram-Positive pathogen that is a major causative agent of pneumonia, otitis media, sepsis and meningitis across the world.
D. E. Briles, J. C. Paton, R. Mukerji, E. Swiatlo, M. J. Crain   +4 more
doaj   +4 more sources

Uptake of Pneumococcal Vaccines Among U.S. Adults After 2022 Update to Recommendations [PDF]

AJPM Focus
Introduction: Updated recommendations for adult pneumococcal vaccination in the U.S. (publication date: January 27, 2022) incorporated 2 new vaccines (15- and 20-valent pneumococcal conjugate vaccines), removed 13-valent pneumococcal conjugate vaccine ...
Ahuva Averin, MPP, Jeffrey Vietri, PhD, Adriano Arguedas Mohs, MD, Sarah J. Willis, PhD, MPH, Alexander Lonshteyn, PhD, Derek Weycker, PhD   +5 more
doaj   +2 more sources

Pneumococcal whole-cell and protein-based vaccines: changing the paradigm

Expert Review of Vaccines, 2017
Introduction: Epidemiologic evaluations of Streptococcus pneumoniae nasopharyngeal (NP) colonization and pneumococcal disease suggest that newer serotypes in future formulations of pneumococcal conjugate vaccines (PCVs) are needed and there may need to ...
Michael E Pichichero
exaly   +2 more sources

Bacterium-like Particles from Corynebacterium pseudodiphtheriticum as Mucosal Adjuvant for the Development of Pneumococcal Vaccines [PDF]

Vaccines
Previously, it was shown that intranasally (i.n.) administered Corynebacterium pseudodiphtheriticum 090104 (Cp) or CP-derived bacterium-like particles (BLPs) improve the immunogenicity of the pneumococcal conjugate vaccine (PCV).
Ramiro Ortiz Moyano, Fernanda Raya Tonetti, Mariano Elean, Yoshiya Imamura, Kohtaro Fukuyama, Yoshihito Suda, Vyacheslav Melnikov, Alexander Suvorov, María Guadalupe Vizoso-Pinto, Haruki Kitazawa, Julio Villena   +10 more
doaj   +2 more sources

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

Risk Management and Healthcare Policy, 2018
Ger T Rijkers,1,2 Laura IE Yousif,1 Simone MC Spoorenberg,3 Frans J van Overveld1 1Department of Science, University College Roosevelt, Middelburg, the Netherlands; 2Department of Medical Microbiology and Immunology, St. Antonius Hospital ...
Rijkers GT, Yousif LIE, Spoorenberg SMC, van Overveld FJ   +3 more
doaj   +1 more source

Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection

Биопрепараты: Профилактика, диагностика, лечение, 2021
Streptococcus pneumoniae infection is the most common cause of high morbidity and mortality among children under 5 years of age, immunocompromised people, and the elderly.
M. V. Savkina, M. A. Krivykh, N. A. Gavrilova, L. V. Sayapina, Yu. I. Obukhov, V. A. Merkulov, V. P. Bondarev   +6 more
doaj   +1 more source

Recent progress in pneumococcal protein vaccines

Frontiers in Immunology, 2023
Pneumococcal infections continue to pose a significant global health concern, necessitating the development of effective vaccines. Despite the progress shown by pneumococcal polysaccharide and conjugate vaccines, their limited coverage and the emergence ...
Sha Li, Hangeri Liang, Shui-Hao Zhao, Xiao-Yan Yang, Zhong Guo   +4 more
doaj   +1 more source